Skip to main content

Rigel Pharmaceuticals Inc 10-K for FY2024

Rigel Pharmaceuticals Inc (RIGL)

10-K 2025-03-04 For: 2024-12-31
View Original
Added on April 06, 2026

About this 10-K

Rigel Pharmaceuticals Inc filed this 10-K on March 4, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$179.28M
up 53.4% from $116.88M a year earlier
Net income
$17.49M
compared with a net loss of $25.09M a year earlier
Diluted EPS
$0.99
compared with -$1.44 a year earlier